NASDAQ : SGHT
Sight Sciences, Inc. — Key statistics
Healthcare · Medical Devices · United States
Last price 9.32 USD (Oct 30, 2026, 4:00 PM EDT) · Market cap 513.42M
Overview · Financial statements · Key statistics · Dividends · Company profile · Price history · Reports
Key statistics
Valuation
| Measure | Value |
|---|
| Market Cap | 513.42M |
| Enterprise Value | 475.64M |
Dates
| Measure | Value |
|---|
| Earnings Date | Nov 4, 2026 |
| Ex-Dividend Date | n/a |
Shares
| Measure | Value |
|---|
| Current Share Class | 55.09M |
| Shares Outstanding | 55.09M |
| Shares Change (YoY) | +4.73% |
| Shares Change (QoQ) | +1.04% |
| Owned by Insiders (%) | 19.30% |
| Owned by Institutions (%) | 32.98% |
| Float | 35.52M |
Ratios
| Measure | Value |
|---|
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 6.16 |
| Forward PS | 5.36 |
| PB Ratio | 9.64 |
| P/TBV Ratio | 9.71 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Evratios
| Measure | Value |
|---|
| EV / Earnings | n/a |
| EV / Sales | 5.70 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financialposition
| Measure | Value |
|---|
| Current Ratio | 4.95 |
| Quick Ratio | 4.45 |
| Debt / Equity | 0.79 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -3.82 |
Financialefficiency
| Measure | Value |
|---|
| Return on Equity (ROE) | -48.42% |
| Return on Assets (ROA) | -10.84% |
| Return on Invested Capital (ROIC) | -11.97% |
| Return on Capital Employed (ROCE) | -23.32% |
| Weighted Average Cost of Capital (WACC) | 17.10% |
| Revenue Per Employee | $448,263 |
| Profits Per Employee | -$159,984 |
| Employee Count | 186 |
| Asset Turnover | 0.74 |
| Inventory Turnover | 1.69 |
Taxes
| Measure | Value |
|---|
| Income Tax | -31,000 |
| Effective Tax Rate | n/a |
Stockprice
| Measure | Value |
|---|
| Beta (5Y) | 2.45 |
| 52-Week Price Change | +84.92% |
| 50-Day Moving Average | 8.59 |
| 200-Day Moving Average | 5.99 |
| Relative Strength Index (RSI) | 59.32 |
| Average Volume (20 Days) | 307,041 |
Shortselling
| Measure | Value |
|---|
| Short Interest | 1.24M |
| Short Previous Month | 1.42M |
| Short % of Shares Out | 2.25% |
| Short % of Float | 3.49% |
| Short Ratio (days to cover) | 3.65 |
Incomestatement
| Measure | Value |
|---|
| Revenue | 83.38M |
| Gross Profit | 73.34M |
| Operating Income | -19.67M |
| Pretax Income | -29.79M |
| Net Income | -29.76M |
| EBITDA | -19.26M |
| EBIT | -19.67M |
| Loss Per Share | -$0.56 |
Balancesheet
| Measure | Value |
|---|
| Cash & Cash Equivalents | 79.75M |
| Total Debt | 41.97M |
| Net Cash | 37.78M |
| Net Cash Per Share | $0.69 |
| Equity (Book Value) | 52.89M |
| Book Value Per Share | 0.97 |
| Working Capital | 80.94M |
Cashflow
| Measure | Value |
|---|
| Operating Cash Flow | -23.24M |
| Capital Expenditures | -93,000 |
| Depreciation & Amortization | 410,000 |
| Net Borrowing | n/a |
| Free Cash Flow | -23.33M |
| FCF Per Share | -$0.42 |
Margins
| Measure | Value |
|---|
| Gross Margin | 87.96% |
| Operating Margin | -23.60% |
| Pretax Margin | -35.73% |
| Profit Margin | -35.69% |
| EBITDA Margin | -23.10% |
| EBIT Margin | -23.60% |
| FCF Margin | n/a |
Dividends
| Measure | Value |
|---|
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| FCF Payout Ratio | n/a |
| Buyback Yield | -4.73% |
| Shareholder Yield | -4.73% |
| Earnings Yield | -5.97% |
| FCF Yield | -4.54% |
Analystforecasts
| Measure | Value |
|---|
| Price Target | $10.17 |
| Price Target Difference | 9.12% |
| Analyst Consensus | Buy |
| Analyst Count | 8 |
| Revenue Growth Forecast (3Y) | 12.27% |
| EPS Growth Forecast (3Y) | n/a |
Stocksplits
| Measure | Value |
|---|
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
| Measure | Value |
|---|
| Altman Z-Score | -1.19 |
| Piotroski F-Score | 4 |
Fairvalue
| Measure | Value |
|---|
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |